These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 21084491)

  • 1. HIV-1 replication in Langerhans and interstitial dendritic cells is inhibited by neutralizing and Fc-mediated inhibitory antibodies.
    Peressin M; Holl V; Schmidt S; Decoville T; Mirisky D; Lederle A; Delaporte M; Xu K; Aubertin AM; Moog C
    J Virol; 2011 Jan; 85(2):1077-85. PubMed ID: 21084491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Broadly Neutralizing Antibodies Display Potential for Prevention of HIV-1 Infection of Mucosal Tissue Superior to That of Nonneutralizing Antibodies.
    Cheeseman HM; Olejniczak NJ; Rogers PM; Evans AB; King DFL; Ziprin P; Liao HX; Haynes BF; Shattock RJ
    J Virol; 2017 Jan; 91(1):. PubMed ID: 27795431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short Communication: Exploring Antibody Potential as Prophylactic/Therapeutic Strategies for Prevention of Early Mucosal HIV-1 Infection.
    Su B; Peressin M; Ducloy C; Penichon J; Mayr LM; Laumond G; Schmidt S; Decoville T; Moog C
    AIDS Res Hum Retroviruses; 2015 Nov; 31(11):1187-91. PubMed ID: 26252799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IgA Targeting Human Immunodeficiency Virus-1 Envelope gp41 Triggers Antibody-Dependent Cellular Cytotoxicity Cross-Clade and Cooperates with gp41-Specific IgG to Increase Cell Lysis.
    Duchemin M; Khamassi M; Xu L; Tudor D; Bomsel M
    Front Immunol; 2018; 9():244. PubMed ID: 29651286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human Herpesvirus 8 Infects and Replicates in Langerhans Cells and Interstitial Dermal Dendritic Cells and Impairs Their Function.
    Rappocciolo G; Jais M; Piazza PA; DeLucia DC; Jenkins FJ; Rinaldo CR
    J Virol; 2017 Oct; 91(20):. PubMed ID: 28768873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neutralizing antibodies inhibit HIV-1 transfer from primary dendritic cells to autologous CD4 T lymphocytes.
    Su B; Xu K; Lederle A; Peressin M; Biedma ME; Laumond G; Schmidt S; Decoville T; Proust A; Lambotin M; Holl V; Moog C
    Blood; 2012 Nov; 120(18):3708-17. PubMed ID: 22955927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Superiority in Rhesus Macaques of Targeting HIV-1 Env gp140 to CD40 versus LOX-1 in Combination with Replication-Competent NYVAC-KC for Induction of Env-Specific Antibody and T Cell Responses.
    Zurawski G; Shen X; Zurawski S; Tomaras GD; Montefiori DC; Roederer M; Ferrari G; Lacabaratz C; Klucar P; Wang Z; Foulds KE; Kao SF; Yu X; Sato A; Yates NL; LaBranche C; Stanfield-Oakley S; Kibler K; Jacobs B; Salazar A; Self S; Fulp W; Gottardo R; Galmin L; Weiss D; Cristillo A; Pantaleo G; Levy Y
    J Virol; 2017 May; 91(9):. PubMed ID: 28202751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immune Effects and Mechanisms of HIV-specific Antibodies Against Viral Infection].
    Su B; Li L; Mou D; Moog C; Wu H; Zhang T
    Bing Du Xue Bao; 2016 Nov; 32(6):830-8. PubMed ID: 30004659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV transmission from infected CD4+ T cells to allogenic T and dendritic cells is inhibited by broadly neutralizing antibodies.
    Ducloy C; Su B; Mayr L; Klingler J; Decoville T; Schmidt S; Laumond G; Salomé N; Bahram S; Moog C
    AIDS; 2018 Jun; 32(10):1239-1245. PubMed ID: 29683853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Receptor usage dictates HIV-1 restriction by human TRIM5α in dendritic cell subsets.
    Ribeiro CM; Sarrami-Forooshani R; Setiawan LC; Zijlstra-Willems EM; van Hamme JL; Tigchelaar W; van der Wel NN; Kootstra NA; Gringhuis SI; Geijtenbeek TB
    Nature; 2016 Dec; 540(7633):448-452. PubMed ID: 27919079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonneutralizing antibodies are able to inhibit human immunodeficiency virus type 1 replication in macrophages and immature dendritic cells.
    Holl V; Peressin M; Decoville T; Schmidt S; Zolla-Pazner S; Aubertin AM; Moog C
    J Virol; 2006 Jun; 80(12):6177-81. PubMed ID: 16731957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of human class-switched polymeric (immunoglobulin M [IgM] and IgA) anti-human immunodeficiency virus type 1 antibodies 2F5 and 2G12.
    Wolbank S; Kunert R; Stiegler G; Katinger H
    J Virol; 2003 Apr; 77(7):4095-103. PubMed ID: 12634368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutralizing antibodies inhibit HIV-1 infection of plasmacytoid dendritic cells by an FcγRIIa independent mechanism and do not diminish cytokines production.
    Lederle A; Su B; Holl V; Penichon J; Schmidt S; Decoville T; Laumond G; Moog C
    Sci Rep; 2014 Aug; 4():5845. PubMed ID: 25132382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Langerin is a natural barrier to HIV-1 transmission by Langerhans cells.
    de Witte L; Nabatov A; Pion M; Fluitsma D; de Jong MA; de Gruijl T; Piguet V; van Kooyk Y; Geijtenbeek TB
    Nat Med; 2007 Mar; 13(3):367-71. PubMed ID: 17334373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neutralizing monoclonal antibodies block human immunodeficiency virus type 1 infection of dendritic cells and transmission to T cells.
    Frankel SS; Steinman RM; Michael NL; Kim SR; Bhardwaj N; Pope M; Louder MK; Ehrenberg PK; Parren PW; Burton DR; Katinger H; VanCott TC; Robb ML; Birx DL; Mascola JR
    J Virol; 1998 Dec; 72(12):9788-94. PubMed ID: 9811714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sexually transmitted founder HIV-1 viruses are relatively resistant to Langerhans cell-mediated restriction.
    Hertoghs N; Nijmeijer BM; van Teijlingen NH; Fenton-May AE; Kaptein TM; van Hamme JL; Kappes JC; Kootstra NA; Hahn BH; Borrow P; Ribeiro CMS; Geijtenbeek TBH
    PLoS One; 2019; 14(12):e0226651. PubMed ID: 31856198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Langerhans Cell-Dendritic Cell Cross-Talk via Langerin and Hyaluronic Acid Mediates Antigen Transfer and Cross-Presentation of HIV-1.
    van den Berg LM; Cardinaud S; van der Aar AM; Sprokholt JK; de Jong MA; Zijlstra-Willems EM; Moris A; Geijtenbeek TB
    J Immunol; 2015 Aug; 195(4):1763-73. PubMed ID: 26170391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro HIV1 infection of CD34+ progenitor-derived dendritic/Langerhans cells at different stages of their differentiation in the presence of GM-CSF/TNF alpha.
    Charbonnier AS; Verrier B; Jacquet C; Massacrier C; Fiers MM; Mallet F; Dezutter-Dambuyant C; Schmitt D
    Res Virol; 1996; 147(2-3):89-95. PubMed ID: 8901426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infection of macrophages and dendritic cells with primary R5-tropic human immunodeficiency virus type 1 inhibited by natural polyreactive anti-CCR5 antibodies purified from cervicovaginal secretions.
    Eslahpazir J; Jenabian MA; Bouhlal H; Hocini H; Carbonneil C; Grésenguet G; Mbopi Kéou FX; LeGoff J; Saïdi H; Requena M; Nasreddine N; de Dieu Longo J; Kaveri SV; Bélec L
    Clin Vaccine Immunol; 2008 May; 15(5):872-84. PubMed ID: 18353923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reconstitution and characterization of antibody repertoires of HIV-1-infected "elite neutralizers".
    Sun Z; Li J; Hu X; Shao Y; Zhang MY
    Antiviral Res; 2015 Jun; 118():1-9. PubMed ID: 25770672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.